Patents by Inventor Stephen Griffin
Stephen Griffin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250366860Abstract: Provided herein is an occlusion device for intrasaccular implantation and/or vascular occlusion comprising: (a) a substantially solid marker having a proximal end, and a distal end; and (b) a low profile resilient mesh body attached to the distal end of the marker, the body having a delivery shape and a deployed shape capable of conforming to aneurysm walls; wherein the body has a diameter greater than a diameter of an aneurysm to be treated. Also provided herein is a kit comprising the occlusion device disclosed herein and a means for delivery thereof. Methods of manufacture and use of the occlusion device disclosed herein are also disclosed.Type: ApplicationFiled: August 19, 2025Publication date: December 4, 2025Inventor: Stephen Griffin
-
Patent number: 12414775Abstract: Provided herein is an occlusion device for intrasaccular implantation and/or vascular occlusion comprising: (a) a substantially solid marker having a proximal end, and a distal end; and (b) a low profile resilient mesh body attached to the distal end of the marker, the body having a delivery shape and a deployed shape capable of conforming to aneurysm walls; wherein the body has a diameter greater than a diameter of an aneurysm to be treated. Also provided herein is a kit comprising the occlusion device disclosed herein and a means for delivery thereof. Methods of manufacture and use of the occlusion device disclosed herein are also disclosed.Type: GrantFiled: June 10, 2024Date of Patent: September 16, 2025Assignee: Stryker Ireland Technology LtdInventor: Stephen Griffin
-
Publication number: 20250204920Abstract: Provided herein is an occlusion device comprising: (a) a substantially solid marker band having an inner and outer diameter, a proximal end, and a distal end; and (b) a resilient mesh body attached within the marker band, wherein the body is a length y, and wherein the body comprises a bolus of additional resilient mesh material of a length x, wherein y is greater than x, and wherein the body extends distally from the marker band having a first delivery shape and a second expandable deployed shape. Also provided herein is a kit comprising the occlusion device disclosed herein and a means for delivery thereof. Methods of manufacture and use of the occlusion device disclosed herein are also disclosed.Type: ApplicationFiled: March 10, 2025Publication date: June 26, 2025Inventor: Stephen Griffin
-
Patent number: 12285175Abstract: Provided herein is an occlusion device comprising: (a) a substantially solid marker band having an inner and outer diameter, a proximal end, and a distal end; and (b) a resilient mesh body attached within the marker band, wherein the body is a length y, and wherein the body comprises a bolus of additional resilient mesh material of a length x, wherein y is greater than x, and wherein the body extends distally from the marker band having a first delivery shape and a second expandable deployed shape. Also provided herein is a kit comprising the occlusion device disclosed herein and a means for delivery thereof. Methods of manufacture and use of the occlusion device disclosed herein are also disclosed.Type: GrantFiled: April 3, 2023Date of Patent: April 29, 2025Assignee: Stryker Ireland Technology Ltd.Inventor: Stephen Griffin
-
Patent number: 12251112Abstract: Provided herein is an occlusion device comprising: (a) continuous mesh structure comprising a medial pinch point; (b) a resilient mesh disc-shaped body extending distally and outward from the medial pinch point; and (c) a compressible mesh carriage extending distally from the medial pinch point on an opposing side of the resilient mesh body of (b), wherein the compressible mesh carriage comprises a pinch point on each end of the carriage, wherein one of the pinch points is the medial pinch point of (a); wherein the continuous mesh structure has a first delivery shape and a second expandable deployed shape, and wherein the length (x) of the resilient mesh body is greater than the length (y) of the compressible mesh carriage in free air and in the deployed shape.Type: GrantFiled: October 5, 2023Date of Patent: March 18, 2025Assignee: Stryker Ireland Technology Ltd.Inventor: Stephen Griffin
-
Publication number: 20250017593Abstract: Provided herein is an occlusion device for implantation into a body lumen or aneurysm comprising, a continuous compressible mesh structure comprising axial mesh carriages configured end to end, wherein each end of each carriage is a pinch point in the continuous mesh structure. Also provided herein is a kit comprising the occlusion device disclosed herein and a means for delivery thereof. Methods of manufacture and use of the occlusion device are also disclosed.Type: ApplicationFiled: September 2, 2024Publication date: January 16, 2025Inventor: Stephen Griffin
-
Publication number: 20240407823Abstract: A method and system for automated and semi-automated predictable, consistent, safe, effective, and lumen-specific and patient-specific cryospray treatment of airway tissue in which treatment duration is automatically set by the system following entry of patient information and treatment location information into the system by the user, and treatment spray is automatically stopped by the system when the automatically selected treatment duration has been achieved as determined by the system.Type: ApplicationFiled: April 22, 2024Publication date: December 12, 2024Inventors: Wendelin Maners, Ellen Sheets, Rafael Cordero, Marc Davidson, Wei Li Fan, David Sherrill, Brian M. Hanley, Amy Sarli, Stephen Griffin, Heather V. Hawkes
-
Patent number: 12076022Abstract: Provided herein is an occlusion device for implantation into a body lumen or aneurysm comprising, a continuous compressible mesh structure comprising axial mesh carriages configured end to end, wherein each end of each carriage is a pinch point in the continuous mesh structure. Also provided herein is a kit comprising the occlusion device disclosed herein and a means for delivery thereof. Methods of manufacture and use of the occlusion device are also disclosed.Type: GrantFiled: June 24, 2022Date of Patent: September 3, 2024Assignee: Stryker Ireland Technology Ltd.Inventor: Stephen Griffin
-
Patent number: 12048469Abstract: A cryosurgery system for application of medical-grade liquid nitrogen to a treatment area via a small, low pressure, open tipped catheter. The system includes a console, including a touch panel computer, a cryogen module, a suction module and an electronics module, and a disposable spray kit. Features include optional low cryogen flow setting to reduce the cryogen flow rate by 50%, improved cryogen flow consistency reducing pressure pulses and peaks, an integrated suction pump for improved consistency and self-checks, specified vent tube areas and corresponding maximum expected pressures during cryospray procedure; optional pressure sensing capability to monitor pressure during a treatment, and novel catheter designs of multilayer and flexible construction providing a variety of spray patterns.Type: GrantFiled: August 28, 2013Date of Patent: July 30, 2024Assignee: CSA MEDICAL, INC.Inventors: Wei Li Fan, Rafael Cordero, Stephen Griffin, Benedict Shia, Sergei Babko-Malyi, Stephen M. McCartin, Brian M. Hanley
-
Publication number: 20240225713Abstract: A method and system for automated and semi-automated predictable, consistent, safe, effective, and lumen-specific and patient-specific cryospray treatment of airway tissue in which treatment duration is automatically set by the system following entry of patient information and treatment location information into the system by the user, and treatment spray is automatically stopped by the system when the automatically selected treatment duration has been achieved as determined by the system.Type: ApplicationFiled: October 25, 2019Publication date: July 11, 2024Inventors: Wendelin Maners, Ellen Sheets, Rafael Cordero, Marc Davidson, Wei Li Fan, David Sherrill, Brian M. Hanley, Amy Sarli, Stephen Griffin, Heather V. Hawkes
-
Patent number: 12029431Abstract: Provided herein is an occlusion device for intrasaccular implantation and/or vascular occlusion comprising: (a) a substantially solid marker having a proximal end, and a distal end; and (b) a low profile resilient mesh body attached to the distal end of the marker, the body having a delivery shape and a deployed shape capable of conforming to aneurysm walls; wherein the body has a diameter greater than a diameter of an aneurysm to be treated. Also provided herein is a kit comprising the occlusion device disclosed herein and a means for delivery thereof. Methods of manufacture and use of the occlusion device disclosed herein are also disclosed.Type: GrantFiled: June 23, 2022Date of Patent: July 9, 2024Assignee: Stryker Ireland Technology, Ltd.Inventor: Stephen Griffin
-
Publication number: 20240130776Abstract: A method and system for automated and semi-automated predictable, consistent, safe, effective, and lumen-specific and patient-specific cryospray treatment of airway tissue in which treatment duration is automatically set by the system following entry of patient information and treatment location information into the system by the user, and treatment spray is automatically stopped by the system when the automatically selected treatment duration has been achieved as determined by the system.Type: ApplicationFiled: October 24, 2019Publication date: April 25, 2024Inventors: Wendelin Maners, Ellen Sheets, Rafael Cordero, Marc Davidson, Wei Li Fan, David Sherrill, Brian M. Hanley, Amy Sarli, Stephen Griffin, Heather V. Hawkes
-
Patent number: 11963709Abstract: A method and system for automated and semi-automated predictable, consistent, safe, effective, and lumen-specific and patient-specific cryospray treatment of airway tissue in which treatment duration is automatically set by the system following entry of patient information and treatment location information into the system by the user, and treatment spray is automatically stopped by the system when the automatically selected treatment duration has been achieved as determined by the system.Type: GrantFiled: October 25, 2019Date of Patent: April 23, 2024Assignee: CSA Medical, Inc.Inventors: Wendelin Maners, Ellen Sheets, Rafael Cordero, Marc Davidson, Wei Li Fan, David Sherrill, Brian M. Hanley, Amy Sarli, Stephen Griffin, Heather V. Hawkes
-
Publication number: 20240032939Abstract: Provided herein is an occlusion device comprising: (a) continuous mesh structure comprising a medial pinch point; (b) a resilient mesh disc-shaped body extending distally and outward from the medial pinch point; and (c) a compressible mesh carriage extending distally from the medial pinch point on an opposing side of the resilient mesh body of (b), wherein the compressible mesh carriage comprises a pinch point on each end of the carriage, wherein one of the pinch points is the medial pinch point of (a); wherein the continuous mesh structure has a first delivery shape and a second expandable deployed shape, and wherein the length (x) of the resilient mesh body is greater than the length (y) of the compressible mesh carriage in free air and in the deployed shape.Type: ApplicationFiled: October 5, 2023Publication date: February 1, 2024Inventor: Stephen Griffin
-
Patent number: 11812971Abstract: Provided herein is an occlusion device comprising: (a) continuous mesh structure comprising a medial pinch point; (b) a resilient mesh disc-shaped body extending distally and outward from the medial pinch point; and (c) a compressible mesh carriage extending distally from the medial pinch point on an opposing side of the resilient mesh body of (b), wherein the compressible mesh carriage comprises a pinch point on each end of the carriage, wherein one of the pinch points is the medial pinch point of (a); wherein the continuous mesh structure has a first delivery shape and a second expandable deployed shape, and wherein the length (x) of the resilient mesh body is greater than the length (y) of the compressible mesh carriage in free air and in the deployed shape. Also provided herein is a kit comprising the occlusion device disclosed herein and a means for delivery thereof. Methods of manufacture and use of the occlusion device disclosed herein are also disclosed.Type: GrantFiled: August 21, 2018Date of Patent: November 14, 2023Assignee: Cerus Endovascular LimitedInventor: Stephen Griffin
-
Publication number: 20230240687Abstract: Provided herein is an occlusion device comprising: (a) a substantially solid marker band having an inner and outer diameter, a proximal end, and a distal end; and (b) a resilient mesh body attached within the marker band, wherein the body is a length y, and wherein the body comprises a bolus of additional resilient mesh material of a length x, wherein y is greater than x, and wherein the body extends distally from the marker band having a first delivery shape and a second expandable deployed shape. Also provided herein is a kit comprising the occlusion device disclosed herein and a means for delivery thereof. Methods of manufacture and use of the occlusion device disclosed herein are also disclosed.Type: ApplicationFiled: April 3, 2023Publication date: August 3, 2023Inventor: Stephen Griffin
-
Patent number: 11648013Abstract: Provided herein is an occlusion device comprising: (a) a substantially solid marker band having an inner and outer diameter, a proximal end, and a distal end; and (b) a resilient mesh body attached within the marker band, wherein the body is a length y, and wherein the body comprises a bolus of additional resilient mesh material of a length x, wherein y is greater than x, and wherein the body extends distally from the marker band having a first delivery shape and a second expandable deployed shape. Also provided herein is a kit comprising the occlusion device disclosed herein and a means for delivery thereof. Methods of manufacture and use of the occlusion device disclosed herein are also disclosed.Type: GrantFiled: November 19, 2020Date of Patent: May 16, 2023Assignee: Cerus Endovascular LimitedInventor: Stephen Griffin
-
Publication number: 20220370087Abstract: Provided herein are methods for protecting distal vessels from emboli during aspiration, the method comprising delivery and deployment of an emboli protection device which is advanced and placed distally relative to the clot burden and thus deep in the neurovascular bed until the device, once deployed, fully opposes a vessel wall creating a circumferential seal across the vessel. The methods utilizing the emboli protection device protect distal vasculature from vulnerable clot emboli which become dislodged during clot removal and/or aspiration and trapped in the emboli protection device.Type: ApplicationFiled: July 26, 2022Publication date: November 24, 2022Inventor: Stephen Griffin
-
Patent number: 11478290Abstract: A method and system for automated and semi-automated predictable, consistent, safe, effective, and lumen-specific and patient-specific cryospray treatment of airway tissue in which treatment duration is automatically set by the system following entry of patient information and treatment location information into the system by the user, and treatment spray is automatically stopped by the system when the automatically selected treatment duration has been achieved as determined by the system.Type: GrantFiled: August 11, 2020Date of Patent: October 25, 2022Assignee: CSA Medical, Inc.Inventors: Wendelin Maners, Ellen Sheets, Rafael Cordero, Marc Davidson, Wei Li Fan, David Sherrill, Brian M. Hanley, Amy Sarli, Stephen Griffin, Heather V. Hawkes
-
Patent number: 11471162Abstract: Provided herein is an occlusion device for implantation into a body lumen or aneurysm comprising, a continuous compressible mesh structure comprising axial mesh carriages configured end to end, wherein each end of each carriage is a pinch point in the continuous mesh structure. Also provided herein is a kit comprising the occlusion device disclosed herein and a means for delivery thereof. Methods of manufacture and use of the occlusion device are also disclosed.Type: GrantFiled: May 9, 2019Date of Patent: October 18, 2022Assignee: Cerus Endovascular LimitedInventor: Stephen Griffin